U.S. stocks are showing mixed movement this Wednesday as investors grapple with the results of the latest Consumer Price Index (CPI) report. The S&P 500 was up a modest 0.15%, while the tech-heavy Nasdaq Composite was down 0.2%. The Dow Jones Industrial Average is faring the best, climbing 0.4%

Embecta, a renowned producer of disposable insulin pen needles and syringes for diabetics, has initiated steps to explore a potential sale after a challenging period where its shares plummeted nearly 70% since its spin-off from Beckton Dickinson.

The recent pullback in artificial intelligence (AI) stocks has created a wave of uncertainty across the market. This pullback raises questions about the future of this once-hot sector. However, amidst the dip lies another path: the potential buying opportunity this recent downward trend presents....

U.S. stocks are experiencing a significant rebound on Tuesday following a three-day sell-off that wiped out a substantial portion of 2024's market gains. The S&P 500 is leading the charge, up over 2.1%, while the Nasdaq and Dow Jones are also experiencing gains exceeding 1.3%.

The US stock market came roaring back this Wednesday, led by a strong rebound rally in technology stocks. Investors are waiting on the Federal Reserve's highly anticipated policy decision later in the day, with expectations leaning towards holding interest rates steady but hinting at a potential ...

Dun & Bradstreet, a venerable name in data and analytics, has recently caught the attention of the investment world with rumors of a potential sale.

Toymaker, Mattel, Inc. saw its stock skyrocket following reports that private equity giant L Catterton has approached the toy manufacturing titan with a takeover offer.